

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | serotonin receptor signaling pathway (GO:0007210) | 9.55882531 |
| 2 | negative regulation of interleukin-8 production (GO:0032717) | 8.84872305 |
| 3 | positive regulation of hair follicle development (GO:0051798) | 8.69563396 |
| 4 | positive regulation of hair cycle (GO:0042635) | 8.69563396 |
| 5 | positive regulation of osteoblast proliferation (GO:0033690) | 8.68845138 |
| 6 | angiogenesis involved in wound healing (GO:0060055) | 8.00912599 |
| 7 | regulation of appetite (GO:0032098) | 7.59441538 |
| 8 | negative regulation of circadian rhythm (GO:0042754) | 7.33342741 |
| 9 | interferon-gamma production (GO:0032609) | 7.31091066 |
| 10 | regulation of Cdc42 GTPase activity (GO:0043088) | 7.20104635 |
| 11 | negative regulation of calcium ion transport into cytosol (GO:0010523) | 6.97491535 |
| 12 | activated T cell proliferation (GO:0050798) | 6.80099350 |
| 13 | hematopoietic stem cell proliferation (GO:0071425) | 6.49359141 |
| 14 | glycoprotein catabolic process (GO:0006516) | 6.29049495 |
| 15 | protein K48-linked deubiquitination (GO:0071108) | 6.28619128 |
| 16 | protein K63-linked deubiquitination (GO:0070536) | 6.14894732 |
| 17 | lymphangiogenesis (GO:0001946) | 6.05009731 |
| 18 | regulation of hair follicle development (GO:0051797) | 5.71479283 |
| 19 | cysteine metabolic process (GO:0006534) | 5.59521587 |
| 20 | glycerophospholipid catabolic process (GO:0046475) | 5.56799743 |
| 21 | carnitine transmembrane transport (GO:1902603) | 5.47478308 |
| 22 | killing of cells of other organism (GO:0031640) | 5.41902531 |
| 23 | disruption of cells of other organism (GO:0044364) | 5.41902531 |
| 24 | sulfation (GO:0051923) | 5.37330633 |
| 25 | thyroid hormone metabolic process (GO:0042403) | 5.24857593 |
| 26 | omega-hydroxylase P450 pathway (GO:0097267) | 5.24749226 |
| 27 | granulocyte differentiation (GO:0030851) | 5.23694171 |
| 28 | mucosal immune response (GO:0002385) | 5.13196216 |
| 29 | carnitine transport (GO:0015879) | 5.02408380 |
| 30 | amino-acid betaine transport (GO:0015838) | 5.02408380 |
| 31 | paraxial mesoderm development (GO:0048339) | 4.88851103 |
| 32 | lipid translocation (GO:0034204) | 4.84339104 |
| 33 | phospholipid translocation (GO:0045332) | 4.84339104 |
| 34 | carnitine metabolic process (GO:0009437) | 4.80566157 |
| 35 | filopodium assembly (GO:0046847) | 4.79720464 |
| 36 | organ or tissue specific immune response (GO:0002251) | 4.72135170 |
| 37 | homocysteine metabolic process (GO:0050667) | 4.61299537 |
| 38 | negative regulation of metanephros development (GO:0072217) | 4.40758555 |
| 39 | defense response to fungus (GO:0050832) | 4.30484878 |
| 40 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 4.30483333 |
| 41 | organic cation transport (GO:0015695) | 4.21179665 |
| 42 | heparan sulfate proteoglycan metabolic process (GO:0030201) | 4.12903992 |
| 43 | righting reflex (GO:0060013) | 4.05384794 |
| 44 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.04024580 |
| 45 | negative regulation of hormone biosynthetic process (GO:0032353) | 4.02734549 |
| 46 | flavonoid metabolic process (GO:0009812) | 3.99190918 |
| 47 | protein sumoylation (GO:0016925) | 3.98665373 |
| 48 | regulation of hair cycle (GO:0042634) | 3.95520787 |
| 49 | startle response (GO:0001964) | 3.95109381 |
| 50 | quaternary ammonium group transport (GO:0015697) | 3.88816929 |
| 51 | positive regulation of cAMP-mediated signaling (GO:0043950) | 3.86546999 |
| 52 | positive regulation of epidermis development (GO:0045684) | 3.81295135 |
| 53 | central nervous system myelination (GO:0022010) | 3.77993685 |
| 54 | axon ensheathment in central nervous system (GO:0032291) | 3.77993685 |
| 55 | negative regulation of calcium ion-dependent exocytosis (GO:0045955) | 3.77255287 |
| 56 | maturation of 5.8S rRNA (GO:0000460) | 3.71638471 |
| 57 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.71469860 |
| 58 | regulation of osteoblast proliferation (GO:0033688) | 3.70071735 |
| 59 | sex differentiation (GO:0007548) | 3.69204900 |
| 60 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 3.67374716 |
| 61 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 3.67374716 |
| 62 | amino-acid betaine metabolic process (GO:0006577) | 3.66810836 |
| 63 | androgen biosynthetic process (GO:0006702) | 3.64011269 |
| 64 | regulation of sarcomere organization (GO:0060297) | 3.62394014 |
| 65 | spindle assembly involved in mitosis (GO:0090307) | 3.62054356 |
| 66 | rRNA catabolic process (GO:0016075) | 3.59237895 |
| 67 | indole-containing compound catabolic process (GO:0042436) | 3.57913531 |
| 68 | indolalkylamine catabolic process (GO:0046218) | 3.57913531 |
| 69 | tryptophan catabolic process (GO:0006569) | 3.57913531 |
| 70 | negative regulation of mesenchymal cell apoptotic process (GO:2001054) | 3.57685654 |
| 71 | regulation of steroid hormone biosynthetic process (GO:0090030) | 3.56176369 |
| 72 | cell killing (GO:0001906) | 3.54516584 |
| 73 | reflex (GO:0060004) | 3.51863108 |
| 74 | negative regulation by host of viral transcription (GO:0043922) | 3.50824436 |
| 75 | negative regulation of hormone metabolic process (GO:0032351) | 3.49922664 |
| 76 | protein-cofactor linkage (GO:0018065) | 3.47400660 |
| 77 | DNA double-strand break processing (GO:0000729) | 3.46627743 |
| 78 | skin development (GO:0043588) | 3.45277257 |
| 79 | positive regulation of vasculogenesis (GO:2001214) | 3.44267624 |
| 80 | dosage compensation (GO:0007549) | 3.40340120 |
| 81 | negative regulation of mast cell activation (GO:0033004) | 3.40309921 |
| 82 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.35445864 |
| 83 | cilium or flagellum-dependent cell motility (GO:0001539) | 3.30410841 |
| 84 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 3.27183936 |
| 85 | endothelial cell proliferation (GO:0001935) | 3.25734024 |
| 86 | sex determination (GO:0007530) | 3.22784744 |
| 87 | regulation of membrane lipid distribution (GO:0097035) | 3.22127328 |
| 88 | low-density lipoprotein particle remodeling (GO:0034374) | 3.20091267 |
| 89 | establishment of protein localization to Golgi (GO:0072600) | 3.17539421 |
| 90 | phosphatidylinositol acyl-chain remodeling (GO:0036149) | 3.15832735 |
| 91 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.14074037 |
| 92 | positive regulation of oligodendrocyte differentiation (GO:0048714) | 3.13325317 |
| 93 | positive regulation of hemostasis (GO:1900048) | 3.12045473 |
| 94 | positive regulation of blood coagulation (GO:0030194) | 3.12045473 |
| 95 | nuclear pore organization (GO:0006999) | 3.04149055 |
| 96 | myoblast migration (GO:0051451) | 3.03780903 |
| 97 | neuron fate determination (GO:0048664) | 3.01331898 |
| 98 | diaphragm development (GO:0060539) | 3.00281105 |
| 99 | purine nucleoside bisphosphate metabolic process (GO:0034032) | 2.99033703 |
| 100 | protein K11-linked deubiquitination (GO:0035871) | 16.2610262 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | GBX2_23144817_ChIP-Seq_PC3_Human | 6.74883329 |
| 2 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 5.30466929 |
| 3 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 4.64270143 |
| 4 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 4.03970706 |
| 5 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 3.47532004 |
| 6 | TAF15_26573619_Chip-Seq_HEK293_Human | 3.30434949 |
| 7 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 3.28896883 |
| 8 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.68621835 |
| 9 | TP53_16413492_ChIP-PET_HCT116_Human | 2.58364004 |
| 10 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 2.53089623 |
| 11 | AR_21572438_ChIP-Seq_LNCaP_Human | 2.51546768 |
| 12 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.16468794 |
| 13 | AR_25329375_ChIP-Seq_VCAP_Human | 2.15110940 |
| 14 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.13211582 |
| 15 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.97076097 |
| 16 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.86109839 |
| 17 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.84868550 |
| 18 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.81487657 |
| 19 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.77434454 |
| 20 | LMO2_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.70615486 |
| 21 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.67688560 |
| 22 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.66556160 |
| 23 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.62691555 |
| 24 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.61814950 |
| 25 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.59100736 |
| 26 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.58752527 |
| 27 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.58435969 |
| 28 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.57958314 |
| 29 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.55225441 |
| 30 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.52068150 |
| 31 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.51768378 |
| 32 | STAT3_23295773_ChIP-Seq_U87_Human | 1.50652302 |
| 33 | EWS_26573619_Chip-Seq_HEK293_Human | 1.48557426 |
| 34 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.45012509 |
| 35 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.44464765 |
| 36 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.44220371 |
| 37 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.44185127 |
| 38 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.44059765 |
| 39 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.42311462 |
| 40 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.41850240 |
| 41 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.38685420 |
| 42 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.36695256 |
| 43 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.34813290 |
| 44 | LUZP1_20508642_ChIP-Seq_ESCs_Mouse | 1.34679724 |
| 45 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.33236923 |
| 46 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.32535913 |
| 47 | TCF4_23295773_ChIP-Seq_U87_Human | 1.30979720 |
| 48 | P300_19829295_ChIP-Seq_ESCs_Human | 1.30847195 |
| 49 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.27122942 |
| 50 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.24889469 |
| 51 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.23898875 |
| 52 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.23898875 |
| 53 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 1.23696144 |
| 54 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.23613184 |
| 55 | SOX3_22085726_ChIP-Seq_MUSCLE_Mouse | 1.18207757 |
| 56 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 1.17791723 |
| 57 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.17302026 |
| 58 | TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 1.16629869 |
| 59 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.16295065 |
| 60 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.13277971 |
| 61 | JUN_21703547_ChIP-Seq_K562_Human | 1.12824383 |
| 62 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.11719501 |
| 63 | FUS_26573619_Chip-Seq_HEK293_Human | 1.11371455 |
| 64 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.10678211 |
| 65 | WDR5_24793694_ChIP-Seq_LNCAP_Human | 1.10481221 |
| 66 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.10440502 |
| 67 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.08010289 |
| 68 | AR_19668381_ChIP-Seq_PC3_Human | 1.07399397 |
| 69 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.07272103 |
| 70 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.07035566 |
| 71 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.03094773 |
| 72 | PHF8_20622853_ChIP-Seq_HELA_Human | 1.01868867 |
| 73 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.98750651 |
| 74 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.98085120 |
| 75 | TBL1_22424771_ChIP-Seq_293T_Human | 0.96565906 |
| 76 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.95659638 |
| 77 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.95364420 |
| 78 | * GATA3_21878914_ChIP-Seq_MCF-7_Human | 0.93632208 |
| 79 | GATA2_21186366_ChIP-Seq_BM-HSCs_Mouse | 0.93182521 |
| 80 | VDR_22108803_ChIP-Seq_LS180_Human | 0.92190458 |
| 81 | SPI1_23127762_ChIP-Seq_K562_Human | 0.90132037 |
| 82 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.90125065 |
| 83 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.89483507 |
| 84 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.89121189 |
| 85 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.88611998 |
| 86 | BRD4_25478319_ChIP-Seq_HGPS_Human | 0.87952795 |
| 87 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.87884539 |
| 88 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.87876509 |
| 89 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.87801390 |
| 90 | SOX9_26525672_Chip-Seq_Limbbuds_Mouse | 0.86145971 |
| 91 | CJUN_26792858_Chip-Seq_BT549_Human | 0.84533463 |
| 92 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.84429513 |
| 93 | ERA_21632823_ChIP-Seq_H3396_Human | 0.84341364 |
| 94 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 0.84044090 |
| 95 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 0.84044090 |
| 96 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 0.83697224 |
| 97 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.82634465 |
| 98 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.81504114 |
| 99 | PCGF4_22325352_ChIP-Seq_293T-Rex_Human | 0.81242137 |
| 100 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.80332430 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003183_abnormal_peptide_metabolism | 8.53873922 |
| 2 | MP0002138_abnormal_hepatobiliary_system | 5.13263718 |
| 3 | MP0005310_abnormal_salivary_gland | 4.77328514 |
| 4 | MP0005670_abnormal_white_adipose | 4.58148274 |
| 5 | MP0002139_abnormal_hepatobiliary_system | 4.27213598 |
| 6 | MP0008875_abnormal_xenobiotic_pharmacok | 4.26370398 |
| 7 | MP0003806_abnormal_nucleotide_metabolis | 3.97588592 |
| 8 | MP0002254_reproductive_system_inflammat | 3.86966340 |
| 9 | MP0001984_abnormal_olfaction | 3.47199367 |
| 10 | MP0004043_abnormal_pH_regulation | 2.76966225 |
| 11 | MP0001919_abnormal_reproductive_system | 2.46020427 |
| 12 | MP0001879_abnormal_lymphatic_vessel | 2.00703301 |
| 13 | MP0005647_abnormal_sex_gland | 1.96082872 |
| 14 | MP0000613_abnormal_salivary_gland | 1.95732720 |
| 15 | MP0005389_reproductive_system_phenotype | 1.95703787 |
| 16 | MP0005187_abnormal_penis_morphology | 1.87290861 |
| 17 | MP0001873_stomach_inflammation | 1.86417454 |
| 18 | MP0005551_abnormal_eye_electrophysiolog | 1.77217313 |
| 19 | MP0001348_abnormal_lacrimal_gland | 1.76098189 |
| 20 | MP0006276_abnormal_autonomic_nervous | 1.71557266 |
| 21 | MP0002006_tumorigenesis | 1.71438469 |
| 22 | MP0006082_CNS_inflammation | 1.70404305 |
| 23 | MP0000569_abnormal_digit_pigmentation | 1.68956974 |
| 24 | MP0009046_muscle_twitch | 1.68333481 |
| 25 | MP0002064_seizures | 1.64264284 |
| 26 | MP0002970_abnormal_white_adipose | 1.62893170 |
| 27 | MP0002928_abnormal_bile_duct | 1.50796956 |
| 28 | MP0005084_abnormal_gallbladder_morpholo | 1.50268409 |
| 29 | MP0002876_abnormal_thyroid_physiology | 1.46443511 |
| 30 | MP0000230_abnormal_systemic_arterial | 1.43950539 |
| 31 | MP0002735_abnormal_chemical_nociception | 1.43109300 |
| 32 | MP0009745_abnormal_behavioral_response | 1.41548395 |
| 33 | MP0005377_hearing/vestibular/ear_phenot | 1.36399575 |
| 34 | MP0003878_abnormal_ear_physiology | 1.36399575 |
| 35 | MP0003315_abnormal_perineum_morphology | 1.35977889 |
| 36 | MP0003724_increased_susceptibility_to | 1.34883767 |
| 37 | MP0004858_abnormal_nervous_system | 1.34525990 |
| 38 | MP0004142_abnormal_muscle_tone | 1.16889405 |
| 39 | MP0003638_abnormal_response/metabolism_ | 1.14697771 |
| 40 | MP0001486_abnormal_startle_reflex | 1.12800750 |
| 41 | MP0001905_abnormal_dopamine_level | 1.11100914 |
| 42 | MP0002736_abnormal_nociception_after | 1.08677551 |
| 43 | MP0001346_abnormal_lacrimal_gland | 1.08583555 |
| 44 | MP0001764_abnormal_homeostasis | 1.05140489 |
| 45 | MP0008961_abnormal_basal_metabolism | 1.04722668 |
| 46 | MP0005167_abnormal_blood-brain_barrier | 1.03368637 |
| 47 | MP0001986_abnormal_taste_sensitivity | 1.01282171 |
| 48 | MP0002269_muscular_atrophy | 0.99638681 |
| 49 | MP0001968_abnormal_touch/_nociception | 0.99327110 |
| 50 | MP0005360_urolithiasis | 0.99287638 |
| 51 | MP0002572_abnormal_emotion/affect_behav | 0.95978225 |
| 52 | MP0000639_abnormal_adrenal_gland | 0.94159864 |
| 53 | MP0001970_abnormal_pain_threshold | 0.92895028 |
| 54 | MP0002127_abnormal_cardiovascular_syste | 0.92177488 |
| 55 | MP0008569_lethality_at_weaning | 0.88532902 |
| 56 | MP0010329_abnormal_lipoprotein_level | 0.87706596 |
| 57 | MP0003936_abnormal_reproductive_system | 0.87462757 |
| 58 | MP0002971_abnormal_brown_adipose | 0.87201100 |
| 59 | MP0000383_abnormal_hair_follicle | 0.84570927 |
| 60 | MP0003195_calcinosis | 0.81671700 |
| 61 | MP0002234_abnormal_pharynx_morphology | 0.79254622 |
| 62 | MP0003646_muscle_fatigue | 0.77575519 |
| 63 | MP0005452_abnormal_adipose_tissue | 0.74994045 |
| 64 | MP0005595_abnormal_vascular_smooth | 0.73081330 |
| 65 | MP0002272_abnormal_nervous_system | 0.70862720 |
| 66 | MP0005253_abnormal_eye_physiology | 0.68517059 |
| 67 | MP0010678_abnormal_skin_adnexa | 0.68111498 |
| 68 | MP0002734_abnormal_mechanical_nocicepti | 0.66756044 |
| 69 | MP0008874_decreased_physiological_sensi | 0.63733839 |
| 70 | MP0000631_abnormal_neuroendocrine_gland | 0.63384228 |
| 71 | MP0005332_abnormal_amino_acid | 0.62860013 |
| 72 | MP0001501_abnormal_sleep_pattern | 0.62623171 |
| 73 | MP0002277_abnormal_respiratory_mucosa | 0.62253964 |
| 74 | MP0002090_abnormal_vision | 0.61795485 |
| 75 | MP0002063_abnormal_learning/memory/cond | 0.59988175 |
| 76 | MP0000371_diluted_coat_color | 0.56967392 |
| 77 | MP0002160_abnormal_reproductive_system | 0.56820865 |
| 78 | MP0002069_abnormal_eating/drinking_beha | 0.55823008 |
| 79 | MP0001440_abnormal_grooming_behavior | 0.55658191 |
| 80 | MP0000685_abnormal_immune_system | 0.55101223 |
| 81 | MP0005174_abnormal_tail_pigmentation | 0.54200454 |
| 82 | MP0002118_abnormal_lipid_homeostasis | 0.53767028 |
| 83 | MP0002210_abnormal_sex_determination | 0.53403363 |
| 84 | MP0004085_abnormal_heartbeat | 0.53252092 |
| 85 | MP0003718_maternal_effect | 0.51376848 |
| 86 | MP0005464_abnormal_platelet_physiology | 0.49816114 |
| 87 | MP0009278_abnormal_bone_marrow | 0.49789164 |
| 88 | MP0009643_abnormal_urine_homeostasis | 0.49765931 |
| 89 | MP0003632_abnormal_nervous_system | 0.49409515 |
| 90 | MP0009642_abnormal_blood_homeostasis | 0.49379589 |
| 91 | MP0001663_abnormal_digestive_system | 0.49374666 |
| 92 | MP0002229_neurodegeneration | 0.47981938 |
| 93 | MP0004924_abnormal_behavior | 0.47622477 |
| 94 | MP0005386_behavior/neurological_phenoty | 0.47622477 |
| 95 | MP0005448_abnormal_energy_balance | 0.46564597 |
| 96 | MP0005164_abnormal_response_to | 0.45278293 |
| 97 | MP0010155_abnormal_intestine_physiology | 0.44877167 |
| 98 | MP0003635_abnormal_synaptic_transmissio | 0.43686959 |
| 99 | MP0001664_abnormal_digestion | 0.43271391 |
| 100 | MP0001270_distended_abdomen | 0.42607622 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Congenital sensorineural hearing impairment (HP:0008527) | 6.56014421 |
| 2 | Retrobulbar optic neuritis (HP:0100654) | 6.21205684 |
| 3 | Optic neuritis (HP:0100653) | 6.21205684 |
| 4 | Lower limb hyperreflexia (HP:0002395) | 6.16811292 |
| 5 | Bilateral sensorineural hearing impairment (HP:0008619) | 5.58381076 |
| 6 | Orchitis (HP:0100796) | 5.46717518 |
| 7 | Keratoconjunctivitis (HP:0001096) | 5.38901590 |
| 8 | Poikiloderma (HP:0001029) | 5.17063488 |
| 9 | Decreased circulating renin level (HP:0003351) | 4.71717510 |
| 10 | Abnormal pancreas size (HP:0012094) | 4.48938239 |
| 11 | Myositis (HP:0100614) | 4.35075703 |
| 12 | Enlarged penis (HP:0000040) | 4.11917579 |
| 13 | Keratoconjunctivitis sicca (HP:0001097) | 4.04345772 |
| 14 | Abnormality of the pericardium (HP:0001697) | 4.00325627 |
| 15 | Hypoplasia of the uterus (HP:0000013) | 3.87619846 |
| 16 | Abolished electroretinogram (ERG) (HP:0000550) | 3.67027078 |
| 17 | Gout (HP:0001997) | 3.66056049 |
| 18 | True hermaphroditism (HP:0010459) | 3.65220021 |
| 19 | Attenuation of retinal blood vessels (HP:0007843) | 3.63075376 |
| 20 | Congenital stationary night blindness (HP:0007642) | 3.61215089 |
| 21 | Unilateral renal agenesis (HP:0000122) | 3.42124718 |
| 22 | Hyperglycinuria (HP:0003108) | 3.35923368 |
| 23 | Hyperventilation (HP:0002883) | 3.28097596 |
| 24 | Bony spicule pigmentary retinopathy (HP:0007737) | 3.22807192 |
| 25 | Abnormality of dentin (HP:0010299) | 3.09266622 |
| 26 | Tinnitus (HP:0000360) | 3.02796076 |
| 27 | Late onset (HP:0003584) | 2.98648756 |
| 28 | Male pseudohermaphroditism (HP:0000037) | 2.98413319 |
| 29 | Xanthomatosis (HP:0000991) | 2.95800613 |
| 30 | Pancreatic cysts (HP:0001737) | 2.85123213 |
| 31 | Bicornuate uterus (HP:0000813) | 2.82186172 |
| 32 | Gonadotropin excess (HP:0000837) | 2.80495191 |
| 33 | Aplasia/hypoplasia of the uterus (HP:0008684) | 2.77841515 |
| 34 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.69180731 |
| 35 | Absent speech (HP:0001344) | 2.67544440 |
| 36 | Preaxial foot polydactyly (HP:0001841) | 2.63426863 |
| 37 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 2.61328930 |
| 38 | Mesangial abnormality (HP:0001966) | 2.60043278 |
| 39 | Anorexia (HP:0002039) | 2.59902725 |
| 40 | Pancreatic fibrosis (HP:0100732) | 2.59674314 |
| 41 | Basal ganglia calcification (HP:0002135) | 2.52013285 |
| 42 | Abnormal drinking behavior (HP:0030082) | 2.48585189 |
| 43 | Polydipsia (HP:0001959) | 2.48585189 |
| 44 | Spastic paraplegia (HP:0001258) | 2.45894966 |
| 45 | Acne (HP:0001061) | 2.40731056 |
| 46 | Abnormality of dental color (HP:0011073) | 2.39925910 |
| 47 | Keratitis (HP:0000491) | 2.39063345 |
| 48 | Spastic tetraparesis (HP:0001285) | 2.37812584 |
| 49 | Chronic hepatic failure (HP:0100626) | 2.37122154 |
| 50 | Bicuspid aortic valve (HP:0001647) | 2.36040816 |
| 51 | Hyperaldosteronism (HP:0000859) | 2.33398750 |
| 52 | Anomalous pulmonary venous return (HP:0010772) | 2.33292755 |
| 53 | Breast carcinoma (HP:0003002) | 2.31157827 |
| 54 | Hemoptysis (HP:0002105) | 2.30057310 |
| 55 | Amelogenesis imperfecta (HP:0000705) | 2.28632244 |
| 56 | Craniofacial hyperostosis (HP:0004493) | 2.27477131 |
| 57 | Subaortic stenosis (HP:0001682) | 2.25898055 |
| 58 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.25898055 |
| 59 | Encephalitis (HP:0002383) | 2.25336458 |
| 60 | Clumsiness (HP:0002312) | 2.22671325 |
| 61 | Germ cell neoplasia (HP:0100728) | 2.21083651 |
| 62 | Frequent falls (HP:0002359) | 2.20756602 |
| 63 | Delayed puberty (HP:0000823) | 2.20654754 |
| 64 | Paraplegia (HP:0010550) | 2.20013140 |
| 65 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.17777912 |
| 66 | Abnormality of glycine metabolism (HP:0010895) | 2.17777912 |
| 67 | Abnormality of renin-angiotensin system (HP:0000847) | 2.15902224 |
| 68 | Pulmonary embolism (HP:0002204) | 2.13419434 |
| 69 | Vertigo (HP:0002321) | 2.11935804 |
| 70 | Abnormal biliary tract physiology (HP:0012439) | 2.10017938 |
| 71 | Bile duct proliferation (HP:0001408) | 2.10017938 |
| 72 | Atrioventricular block (HP:0001678) | 2.07781454 |
| 73 | Aplasia/Hypoplasia of the spleen (HP:0010451) | 2.07498729 |
| 74 | Retinal atrophy (HP:0001105) | 2.04413241 |
| 75 | Abnormality of the pulmonary veins (HP:0011718) | 2.02720132 |
| 76 | CNS demyelination (HP:0007305) | 2.01835727 |
| 77 | Ileus (HP:0002595) | 2.01170491 |
| 78 | Gangrene (HP:0100758) | 2.00964614 |
| 79 | Glucose intolerance (HP:0000833) | 2.00248435 |
| 80 | Opisthotonus (HP:0002179) | 1.99230087 |
| 81 | Hyperactive renin-angiotensin system (HP:0000841) | 1.98996895 |
| 82 | Arterial thrombosis (HP:0004420) | 1.98327793 |
| 83 | Abnormality of the dental pulp (HP:0006479) | 1.96241000 |
| 84 | Constricted visual fields (HP:0001133) | 1.95163634 |
| 85 | Hyperkalemia (HP:0002153) | 1.94545800 |
| 86 | Abnormal glucose tolerance (HP:0001952) | 1.93542623 |
| 87 | Tapered finger (HP:0001182) | 1.92948785 |
| 88 | Loss of speech (HP:0002371) | 1.92133010 |
| 89 | Glomerulopathy (HP:0100820) | 1.90452564 |
| 90 | Abnormality of proline metabolism (HP:0010907) | 1.90052762 |
| 91 | Hydroxyprolinuria (HP:0003080) | 1.90052762 |
| 92 | Stage 5 chronic kidney disease (HP:0003774) | 1.90031434 |
| 93 | Delayed closure of the anterior fontanelle (HP:0001476) | 1.86309800 |
| 94 | Hyperglycinemia (HP:0002154) | 1.75491385 |
| 95 | Pancreatitis (HP:0001733) | 1.73199810 |
| 96 | Cranial hyperostosis (HP:0004437) | 1.72599389 |
| 97 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 1.72494343 |
| 98 | Pulmonary infiltrates (HP:0002113) | 1.71528545 |
| 99 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 1.71101419 |
| 100 | Ventricular fibrillation (HP:0001663) | 1.71074219 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FRK | 9.68245042 |
| 2 | WNK3 | 7.45944157 |
| 3 | TXK | 5.09384313 |
| 4 | PINK1 | 4.09337150 |
| 5 | BLK | 3.20312398 |
| 6 | EEF2K | 3.13954394 |
| 7 | MAPKAPK3 | 2.41822524 |
| 8 | YES1 | 2.39783590 |
| 9 | ZAK | 2.08002838 |
| 10 | FER | 1.95578687 |
| 11 | CDK12 | 1.89195925 |
| 12 | IRAK1 | 1.63240138 |
| 13 | ADRBK2 | 1.42406826 |
| 14 | MAPKAPK5 | 1.39971920 |
| 15 | NTRK3 | 1.37750816 |
| 16 | PRKCZ | 1.35926877 |
| 17 | TRPM7 | 1.27462831 |
| 18 | GRK1 | 1.19799208 |
| 19 | EIF2AK3 | 1.16159775 |
| 20 | TAOK3 | 1.02292573 |
| 21 | CSK | 1.01946125 |
| 22 | STK39 | 1.00303262 |
| 23 | MAPK13 | 0.97190924 |
| 24 | OXSR1 | 0.95215909 |
| 25 | PIK3CA | 0.87681080 |
| 26 | STK38L | 0.79103435 |
| 27 | EIF2AK2 | 0.75084655 |
| 28 | BCKDK | 0.74035431 |
| 29 | NEK1 | 0.71503136 |
| 30 | PRKD3 | 0.68690004 |
| 31 | CHEK2 | 0.67219446 |
| 32 | WNK4 | 0.64708404 |
| 33 | CSF1R | 0.64199101 |
| 34 | ADRBK1 | 0.60640918 |
| 35 | GRK7 | 0.59229225 |
| 36 | PRKD2 | 0.58476641 |
| 37 | PRKCH | 0.56692542 |
| 38 | RPS6KB2 | 0.56565628 |
| 39 | IGF1R | 0.54710977 |
| 40 | PLK4 | 0.52990699 |
| 41 | MAP3K7 | 0.51186037 |
| 42 | PRKG1 | 0.50168021 |
| 43 | MAPK11 | 0.49969376 |
| 44 | FLT3 | 0.48538850 |
| 45 | STK24 | 0.48255912 |
| 46 | PRKCB | 0.45153173 |
| 47 | LIMK1 | 0.43323930 |
| 48 | TLK1 | 0.43050746 |
| 49 | MKNK1 | 0.41966444 |
| 50 | PRKCA | 0.41908004 |
| 51 | TIE1 | 0.38459877 |
| 52 | PDK1 | 0.36634101 |
| 53 | MAP2K1 | 0.36364832 |
| 54 | CAMK1D | 0.35597176 |
| 55 | JAK1 | 0.33359656 |
| 56 | BMPR1B | 0.33016493 |
| 57 | GSK3A | 0.32697508 |
| 58 | CAMK1 | 0.31781726 |
| 59 | CAMK2A | 0.30568598 |
| 60 | RPS6KA5 | 0.29159481 |
| 61 | RPS6KA4 | 0.26057869 |
| 62 | TTK | 0.25289506 |
| 63 | TEC | 0.25271727 |
| 64 | PRKACA | 0.25117785 |
| 65 | RPS6KA3 | 0.24290112 |
| 66 | RPS6KA2 | 0.23048143 |
| 67 | MAPK7 | 0.21419839 |
| 68 | LYN | 0.20965664 |
| 69 | CDK3 | 0.20875929 |
| 70 | CSNK1A1 | 0.20249394 |
| 71 | MAPK10 | 0.18936921 |
| 72 | INSRR | 0.18270242 |
| 73 | INSR | 0.18021125 |
| 74 | PRKAA2 | 0.17410647 |
| 75 | GSK3B | 0.17083753 |
| 76 | PRKCQ | 0.16199138 |
| 77 | TGFBR2 | 0.15902916 |
| 78 | MKNK2 | 0.15631920 |
| 79 | MAPK12 | 0.15183540 |
| 80 | KIT | 0.13934853 |
| 81 | PRKCE | 0.13846325 |
| 82 | PRKCG | 0.13706645 |
| 83 | SIK2 | 0.13057742 |
| 84 | DYRK2 | 0.12761500 |
| 85 | MAPK14 | 0.11871258 |
| 86 | IKBKB | 0.11827897 |
| 87 | RPS6KB1 | 0.11570273 |
| 88 | MAPK1 | 0.10977625 |
| 89 | MAP3K8 | 0.10900485 |
| 90 | STK38 | 0.10823583 |
| 91 | MAP4K2 | 0.10265008 |
| 92 | LMTK2 | 0.10218905 |
| 93 | OBSCN | 0.10162506 |
| 94 | SIK1 | 0.09946333 |
| 95 | PRKDC | 0.08760208 |
| 96 | NEK2 | 0.08561363 |
| 97 | CDK6 | 0.08469370 |
| 98 | MET | 0.07903968 |
| 99 | MOS | 0.07892588 |
| 100 | PLK2 | 0.07670058 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 6.78187495 |
| 2 | Selenocompound metabolism_Homo sapiens_hsa00450 | 3.91736899 |
| 3 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 3.22570758 |
| 4 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 2.64117330 |
| 5 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.61391139 |
| 6 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.53794630 |
| 7 | Ether lipid metabolism_Homo sapiens_hsa00565 | 2.42373834 |
| 8 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 2.41884685 |
| 9 | Histidine metabolism_Homo sapiens_hsa00340 | 2.39121289 |
| 10 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.33002400 |
| 11 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 2.32963059 |
| 12 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 2.21959570 |
| 13 | Nicotine addiction_Homo sapiens_hsa05033 | 2.02026280 |
| 14 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.92074757 |
| 15 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.79517431 |
| 16 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.79026981 |
| 17 | Salivary secretion_Homo sapiens_hsa04970 | 1.76237174 |
| 18 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.72009605 |
| 19 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.71340212 |
| 20 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.69976565 |
| 21 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.64517622 |
| 22 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.61764272 |
| 23 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.59676285 |
| 24 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.49137338 |
| 25 | Phototransduction_Homo sapiens_hsa04744 | 1.48400323 |
| 26 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.45057899 |
| 27 | Proteasome_Homo sapiens_hsa03050 | 1.43934064 |
| 28 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.42787295 |
| 29 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.39939492 |
| 30 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.37719878 |
| 31 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.37464712 |
| 32 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.33006630 |
| 33 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.19433826 |
| 34 | Olfactory transduction_Homo sapiens_hsa04740 | 1.15671198 |
| 35 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.14748286 |
| 36 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.14061538 |
| 37 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.13838566 |
| 38 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 1.12209712 |
| 39 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.09860863 |
| 40 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.07850370 |
| 41 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.04925700 |
| 42 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.99699751 |
| 43 | Lysine degradation_Homo sapiens_hsa00310 | 0.96359658 |
| 44 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.95040787 |
| 45 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.94566781 |
| 46 | Peroxisome_Homo sapiens_hsa04146 | 0.93099688 |
| 47 | ABC transporters_Homo sapiens_hsa02010 | 0.92481313 |
| 48 | Morphine addiction_Homo sapiens_hsa05032 | 0.91144339 |
| 49 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.86041582 |
| 50 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.84813177 |
| 51 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.80580264 |
| 52 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.80319526 |
| 53 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.80265162 |
| 54 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.79186338 |
| 55 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.73706746 |
| 56 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.70281199 |
| 57 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.70156601 |
| 58 | Homologous recombination_Homo sapiens_hsa03440 | 0.56429756 |
| 59 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.55455206 |
| 60 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.54207306 |
| 61 | Metabolic pathways_Homo sapiens_hsa01100 | 0.54076112 |
| 62 | RNA transport_Homo sapiens_hsa03013 | 0.53619156 |
| 63 | Base excision repair_Homo sapiens_hsa03410 | 0.50832045 |
| 64 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.50655976 |
| 65 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.50530800 |
| 66 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.46819450 |
| 67 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.46001020 |
| 68 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.44308562 |
| 69 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.42069537 |
| 70 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.39411272 |
| 71 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.38365594 |
| 72 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.37546088 |
| 73 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.36392203 |
| 74 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.36010311 |
| 75 | GABAergic synapse_Homo sapiens_hsa04727 | 0.35920002 |
| 76 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.35445263 |
| 77 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.35179384 |
| 78 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.35173293 |
| 79 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.33290955 |
| 80 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.31626760 |
| 81 | Taste transduction_Homo sapiens_hsa04742 | 0.26112963 |
| 82 | Platelet activation_Homo sapiens_hsa04611 | 0.25235720 |
| 83 | Retinol metabolism_Homo sapiens_hsa00830 | 0.23463382 |
| 84 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.23199229 |
| 85 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.22758064 |
| 86 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.22407785 |
| 87 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.22344320 |
| 88 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.21223219 |
| 89 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.20531383 |
| 90 | Adherens junction_Homo sapiens_hsa04520 | 0.19551685 |
| 91 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.19214417 |
| 92 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.16909787 |
| 93 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.15912900 |
| 94 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.15510698 |
| 95 | Huntingtons disease_Homo sapiens_hsa05016 | 0.13784449 |
| 96 | Long-term depression_Homo sapiens_hsa04730 | 0.13008216 |
| 97 | DNA replication_Homo sapiens_hsa03030 | 0.10896487 |
| 98 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.10318126 |
| 99 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.09201419 |
| 100 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.09002402 |

